Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/1998
10/29/1998WO1998047888A1 Kodaistatins a, b, c and d, a process for their production and their use
10/29/1998WO1998047879A1 Substituted phenyl derivatives, their preparation and use
10/29/1998WO1998047875A1 Process and intermediates for the preparation of 4'-trifluoromethyl-biphenyl-2-carboxylic acid (1,2,3,4-tetrahydro-isoquinolin-6-yl)-amide
10/29/1998WO1998047866A2 Arylsecocholadiene derivatives
10/29/1998WO1998047857A1 Solid compositions suitable for oral administration comprising l-carnitine or alkanoyl-l-carnitine choline tartrate
10/29/1998WO1998047854A1 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
10/29/1998WO1998047529A1 Combinations of antigen and mucosal binding component for inducing specific immunological tolerance
10/29/1998WO1998047514A1 Use of an nk-1 receptor antagonist and an ssri for treating obesity
10/29/1998WO1998020000A3 Substituted 3-benzylpyrazoles
10/29/1998CA2287445A1 Arylsecocholadiene derivatives
10/29/1998CA2287397A1 Use of an nk-1 receptor antagonist and an ssri for treating obesity
10/29/1998CA2286681A1 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
10/29/1998CA2286108A1 Process and intermediates for the preparation of 4'-trifluoromethyl-biphenyl-2-carboxylic acid (1,2,3,4-tetrahydro-isoquinolin-6-yl)-amide
10/29/1998CA2285424A1 Substituted phenyl derivatives, their preparation and use
10/28/1998EP0873993A1 Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
10/28/1998EP0873992A1 Indene compounds having activity as SERMs
10/28/1998EP0873361A2 Nuclear receptor ligands and ligand binding domains
10/28/1998EP0873309A1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands
10/28/1998EP0873295A1 Dimer-selective rxr modulators and methods for their use
10/28/1998EP0873129A1 Anion exchange resin-containing tablets
10/28/1998EP0873124A1 A method of treating hypercholesterolemia and related disorders
10/28/1998EP0873116A1 Anti-inflammatory and infection protective effects of sesamin-based lignans
10/28/1998EP0752999B1 2,4-diphosphonoglutaric acid derivatives, methods of preparing such compounds and drugs containing them
10/28/1998EP0715620B1 1-arylcycloalkyl sulphides, sulphoxides and sulphones for the treatment of depression, anxiety and parkinson's disease
10/28/1998EP0605484B1 Peptides having growth hormone releasing activity
10/28/1998CN1197072A New N-aryl piperidine compounds, process for their preparation and pharmaceutical compositions containing them
10/28/1998CN1196942A Compound Chinese and western medicinal compsn. for treating 'down elimination' diabetes
10/28/1998CN1196941A Compound Chinese and western medicinal compsn. for treating 'medium elimination' diabetes
10/28/1998CN1196940A Compound Chinese and western medicinal compsn. for treating 'upper elimination' diabetes
10/28/1998CN1040440C Process for preparing dehydrocycloclausenamide derivatives
10/28/1998CN1040432C Spiro piperdines derivatives and its prepn. and applications
10/27/1998US5827898 Use of bisphenolic compounds to treat type II diabetes
10/27/1998US5827897 Insulin-resistance in a mammal treated by administering a synergistic mixture of a retinoid and a fatty acid; antidiabetic agents
10/27/1998US5827896 Pinitol and derivatives thereof for the treatment of metabolic disorders
10/27/1998US5827892 Treatment and prevention of atherosclerosis
10/27/1998US5827883 Topical drug delivery; side effect reduction
10/27/1998US5827880 Salen-metal complexes
10/27/1998US5827869 Substituted biphenyl isoxazole sulfonamides
10/27/1998US5827856 Method of treating insulin resistance
10/27/1998US5827855 Anticholesterol agents treating cardiovascular disorders; enzyme inhibitors
10/27/1998US5827849 Cyclic dericatives, pharmaceutical compositions containing these compounds and processes for preparing them
10/27/1998US5827844 Having an n-pyrrolidinyl or n-piperidinyl group
10/27/1998US5827828 Sulfated glycolipids and antibodies thereto for prophylaxis or therapy of diabetes
10/27/1998US5827740 A mixture of glucocorticoids and an adenosine monophosphates inducing the fat cells by cell differentiation
10/27/1998US5827683 Nucleic acids encoding BSSL variants
10/27/1998US5827536 Anticholesterol drug solution comprising a solubilizer nonionic surfactant diethylene glycol monoethyl ether
10/27/1998CA2063721C Mycobacterium chelonae polar glycopeptidolipids-based immune booster medication
10/22/1998WO1998046765A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
10/22/1998WO1998046764A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants
10/22/1998WO1998046751A1 Osteoprotegerin binding proteins and receptors
10/22/1998WO1998046743A1 Novel ldl-receptor
10/22/1998WO1998046648A1 Interactive system for substance presentation and elimination
10/22/1998WO1998046644A1 Novel protein and process for producing the same
10/22/1998WO1998046642A1 MODIFIED TNFα MOLECULES, DNA ENCODING SUCH MODIFIED TNFα MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFα MOLECULES AND DNA
10/22/1998WO1998046604A1 5,6,7-trisubstituted-4-aminopyridol[2,3-d]pyrimidine compounds
10/22/1998WO1998046603A1 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
10/22/1998WO1998046590A1 Thermogenic composition and benzazepine thermogenics
10/22/1998WO1998046585A1 Inhibitors of cholesterol esterase
10/22/1998WO1998046264A1 Antagonistic anti-avb3 integrin antibodies
10/22/1998WO1998046257A1 Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods
10/22/1998WO1998046244A1 Vegetable extract, method for preparation thereof and its applications in human and veterinary medicine
10/22/1998WO1998046243A2 Pharmaceutical compositions having appetite suppressant activity
10/22/1998CA2781623A1 Novel protein binding to osteoclastogenesis inhibitory factor and process for producing the same
10/22/1998CA2706609A1 Osteoprotegerin binding proteins and receptors
10/22/1998CA2584411A1 Pharmaceutical compositions having appetite suppressant activity
10/22/1998CA2289476A1 Modified tnf.alpha. molecules, dna encoding such modified tnf.alpha. molecules and vaccines comprising such modified tnf.alpha. molecules and dna
10/22/1998CA2287465A1 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
10/22/1998CA2286592A1 5,6,7-trisubstituted-4-aminopyridol[2,3-d]pyrimidine compounds
10/22/1998CA2286263A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
10/22/1998CA2284726A1 Antagonistic anti-avb3 integrin antibodies
10/22/1998CA2284525A1 Inhibitors of cholesterol esterase
10/22/1998CA2282390A1 Thermogenic composition and benzazepine thermogenics
10/22/1998CA2234399A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor
10/22/1998CA2231740A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor
10/21/1998EP0872244A1 Cosmetic or pharmaceutical composition containing an Andiroba extract
10/21/1998EP0872243A1 Herb composition, herbal paste and herbal plaster made from the same
10/21/1998EP0872235A1 Therapeutic agents
10/21/1998EP0871883A1 Compounds and methods related to parathyroid hormone-like protein
10/21/1998EP0871742A2 Vectors and viruses for use in gene therapy
10/21/1998EP0871670A2 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR
10/21/1998EP0871669A1 Human somatostatin-like receptor
10/21/1998EP0871657A1 Methods for treatment and prevention of diabetes
10/21/1998EP0871626A1 Novel triazolones as apolipoprotein-b synthesis inhibitors
10/21/1998EP0871611A1 New derivatives of glycylanilides, preparation and therapeutical application
10/21/1998EP0871474A1 Generation of human insulin
10/21/1998EP0871463A1 Regulation of eating behavior
10/21/1998EP0871462A1 Anti-obesity proteins
10/21/1998EP0871457A1 Isolated stromal cells and methods of using the same
10/21/1998EP0871455A1 In vitro growth of functional islets of langerhans and in vivo uses thereof
10/21/1998EP0871451A1 Stanol composition and the use thereof
10/21/1998EP0871443A1 Advanced glycation end-product intermediaries and post-amadori inhibition
10/21/1998EP0871439A1 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds
10/21/1998CN1196732A Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/21/1998CN1196730A Novel polymorphic forms of troglitazone having enhanced anti-brabetic activity and process for their preparation
10/21/1998CN1196729A Novel heterocyclic compounds
10/21/1998CN1196720A Novel vitamin D analogues
10/21/1998CN1040324C New thiazolidindiones and drugs containing them
10/21/1998CN1040323C Thiazolidine derivative
10/20/1998US5824784 Genetic engineering with polypeptides and proteins
10/20/1998US5824696 Medicaments
1 ... 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 ... 1298